Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 27 2015

Print

Search Results for 'Financial Reports: Biogen Idec'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 25, 2013
MS franchise continues growth Read More »
By Gil Roth
Published January 28, 2013
MS franchise continues growth trend Read More »
Published July 26, 2011
Tysabri revenues climb 28% Read More »
Published February 16, 2006
Biogen Idec 4Q Revenues: $633 million (+8%) 4Q Earnings: $56 million (+94%) FY Revenues: $2.4 billion (+10%) FY Earnings: $161 million (+541%) Comments: Revenues for the quarter and full year were driven by Rituxan and Avonex. R… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On